Research site

Sheffield, South Yorkshire S5 7AU

1 studies enrolling now · 7 studies all time

What they study most

ALS Caused by Superoxide Dismutase 1 (SOD1) Mutation, Amyotrophic Lateral Sclerosis, Anemia, Hypophosphatasia (HPP), Non-Dialysis-Dependent Chronic Kidney Disease, Small Cell Lung Cancer

Studies at this site

• Registry of Patients With Hypophosphatasia — Enrolling by invitation
• Long-Term Evaluation of BIIB067 (Tofersen) — Completed
• An Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of BIIB067 (Tofersen) in Adults With Inherited Amyotrophic Lateral Sclerosis (ALS) — Completed
• Study to Assess the Safety, Tolerability, Pharmacokinetics, and Effect on Disease Progression of BIIB078 Administered to Previously Treated Adults C9ORF72-Associated Amyotrophic Lateral Sclerosis (ALS) — Stopped early
• Study to Evaluate Vadadustat for the Correction of Anemia in Participants With Non-dialysis-dependent Chronic Kidney Disease — Completed
• A Study to Assess the Safety, Tolerability, and Pharmacokinetics of BIIB078 in Adults With C9ORF72-Associated Amyotrophic Lateral Sclerosis — Completed
• Phase Ib/II Study of M3814 With Etoposide and Cisplatin in Small Cell Lung Cancer (SCLC) Extensive Disease (ED) — Stopped early